Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients with Advanced Solid Tumors


Collapse Overview 
Collapse sponsor award id
BLU


Collapse Biography 

Collapse Time 
Collapse start date
2022-10-24

Collapse end date
2023-10-23